Salute e Benessere
Bioresorbable Implants Market to Double, Hitting US$ 14.34 Billion by 2033 as Orthopedics and Cardiovascular Applications Redefine Surgical Outcomes | by DataM Intelligence
In 2024, . Among them, accounted for the largest share, widely used in orthopedic fixation. are gaining traction in cardiovascular applications where controlled degradation is critical. Metallic bioresorbables, although smaller ( US$ 1.5 billion in 2024), are emerging fast with magnesium-based implants showing strong clinical promise.
, fueled by sports injury treatments, trauma fixation, and pediatric orthopedics. Bioresorbable screws, pins, and plates are becoming the standard in ACL reconstruction and fracture repair.
led by bioresorbable stents. With rising cases of coronary artery disease, these stents are gaining market traction due to lower risk of late thrombosis.
reflecting their central role in advanced surgical procedures. are growing rapidly as minimally invasive surgeries shift toward outpatient settings.
The U.S., valued at leads the market due to:
Japan's market, valued at is expanding rapidly. Growth is supported by:
Stryker remains at the forefront with Its innovations in trauma fixation and sports medicine products continue to dominate the orthopedic landscape.
Johnson & Johnson generated , expanding aggressively into cardiovascular and orthopedic implants. The 2025 launch of advanced PLLA-based fixation systems reinforced its strong U.S. market presence.
Bioretec is a rising leader with pioneering magnesium-based implants. In 2025, it secured FDA clearance for its marking a milestone in metallic bioresorbables.
Both companies are scaling polymer implant portfolios with a focus on sports injuries and pediatric applications. Combined, they generated
Evonik plays a key role as a supplying polymers (Resomer® range) that power multiple bioresorbable implant lines across the industry.
The is entering its most transformative phase. Four key forces will define its trajectory:
The is no longer a niche-it is With the U.S. leading clinical adoption and Japan setting benchmarks in innovation, the sector offers
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter , LinkedIn and Facebook .
Sai Kiran
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad , Telangana 500039
+1 877-441-4866
Sai.k@datamintelligence.com
https://www.datamintelligence.com/
Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bioresorbable-implants-market-to-double-hitting-us-14-34-billion-by-2033-as-orthopedics-and-cardiovascular-applications-redefine-surgical-outcomes--by-datam-intelligence-302572336.html